| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.30B | — | +18.4% |
| R&D Expense | $744.0M | — | +56.6% |
| SG&A Expense | $1.70B | — | +33.9% |
| Operating Income | $470.0M | — | +8.5% |
| Pre-tax Income | $433.0M | — | -40.9% |
| Income Tax | -$19.0M | — | -117.9% |
| Net Income | $452.0M | — | -27.9% |
| EPS (Basic) | $0.32 | — | -28.9% |
| EPS (Diluted) | $0.31 | — | -29.5% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.84B | -16.1% | -64.0% |
| Accounts Receivable | $4.93B | -6.8% | +42.9% |
| Inventory | $6.91B | +8.8% | -19.4% |
| Current Assets | $25.20B | +0.8% | -23.7% |
| Total Assets | $75.77B | -0.2% | +7.7% |
| Current Liabilities | $24.36B |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.18B | — | +402.1% |
| Investing Cash Flow | -$793.0M | — | -3347.8% |
| Financing Cash Flow | -$1.35B | — | -69.6% |
| -2.2% |
| Long-term Debt | $17.70B | -18.6% | -1.0% |
| Stockholders' Equity | $24.77B | +0.3% | -1.8% |